User profiles for Z. A. Miller

Zachary Miller

Associate Professor of Neurology, UCSF Memory and Aging Center
Verified email at memory.ucsf.edu
Cited by 7485

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease

…, A Lazaris, A Cantwell, J Vogel, M Santos, ZA Miller… - Brain, 2016 - academic.oup.com
See Sarazin et al . (doi: 10.1093/brain/aww041 ) for a scientific commentary on this article.
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique …

Speech and language impairments in behavioral variant frontotemporal dementia: a systematic review

…, P Battista, AM García, IE Allen, ZA Miller… - Neuroscience & …, 2021 - Elsevier
Although behavioral variant frontotemporal dementia (bvFTD) is classically defined by
behavioral and socio-emotional changes, impairments often extend to other cognitive functions. …

Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease

…, ML Gorno-Tempini, ZA Miller, HJ Rosen, BL Miller… - Brain, 2017 - academic.oup.com
Neuropathological and in vivo studies have revealed a tight relationship between tau
pathology and cognitive impairment across the Alzheimer’s disease spectrum. However, tau …

Typical and atypical pathology in primary progressive aphasia variants

EG Spinelli, ML Mandelli, ZA Miller… - Annals of …, 2017 - Wiley Online Library
Objective To characterize in vivo signatures of pathological diagnosis in a large cohort of
patients with primary progressive aphasia (PPA) variants defined by current diagnostic …

Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET

…, M Janabi, OH Lesman-Segev, ZA Miller… - Science translational …, 2020 - science.org
β-Amyloid plaques and tau-containing neurofibrillary tangles are the two neuropathological
hallmarks of Alzheimer’s disease (AD) and are thought to play crucial roles in a …

Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector

…, SY Yoon, H Yuan, G Li, ZA Miller, BL Miller… - Nature medicine, 2018 - nature.com
Efforts to develop drugs for Alzheimer's disease (AD) have shown promise in animal studies,
only to fail in human trials, suggesting a pressing need to study AD in human model systems…

Clinicopathological correlations in behavioural variant frontotemporal dementia

…, AW Kao, KA Vossel, MC Tartaglia, ZA Miller… - Brain, 2017 - academic.oup.com
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural
variant frontotemporal dementia (bvFTD) poses a daunting challenge for clinicians but will …

Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease

…, D Cuevas, C Cosme, M Hepker, JH Hwang, ZA Miller… - Brain, 2021 - academic.oup.com
Co-pathologies play an important role in the expression of the Alzheimer’s disease clinical
phenotype and may influence treatment efficacy. Early-onset Alzheimer’s disease, defined as …

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

…, M Janabi, PM Ghosh, M Santos, ZA Miller… - Annals of …, 2015 - Wiley Online Library
Determining the relative contribution of amyloid plaques and neurofibrillary tangles to brain
dysfunction in Alzheimer disease is critical for therapeutic approaches, but until recently …

TDP-43 frontotemporal lobar degeneration and autoimmune disease

ZA Miller, KP Rankin, NR Graff-Radford… - Journal of Neurology …, 2013 - jnnp.bmj.com
Background The aetiology and pathogenesis of non-genetic forms of frontotemporal dementia
(FTD) is unknown and even with the genetic forms of FTD, pathogenesis remains elusive. …